Contact Support
Device cleaning guidelines
Supporting peak needs
Alaris™ System Pump administration sets
User training resources
BD Alaris™ System clinical resources
Customer support
BD Alaris™ FAQs
Q.
Will adding a long extension set on the end of the standard BD Alaris™ administration set to keep the pumps outside the patient impact the pump performance?
A.
BD understands that some of our customers are connecting extra-long extension sets in order to keep the pumps outside the patient room. The information here addresses most commonly asked questions related to this practice.
Q.
What are some clinical practices to consider implementing when exploring options to conserve the BD Alaris™ Pump Module Administration Sets in the event of low inventory or stock-out scenario?
A.
To help you make educated practice decisions, we are providing you with some considerations, click here for details. For information on calculating Flow Rates, click here.
Additional resources: View the ECRI lab webcast on Infusion Therapy - Conserving Supplies in the Age of COVID-19.
Q.
What are the guidelines on set change policies to support conserving the BD Alaris™ Pump module administration sets in the event of low inventory or stock-out?
A.
We have been receiving customer inquiries regarding extending pump set change intervals for the BD Alaris™ Pump Infusion Set. The BD Alaris™ Pump Set labeling includes the following related to set change intervals: “The set should be changed according to facility protocol or in accordance with currently recognized guidelines for IV therapy.” BD Alaris™ functional performance testing for rate accuracy, occlusion detection and air in line supports the use of the BD Alaris™ Pump Infusion Set for up to 96 hours (excluding blood or blood products). The information here provides well-accepted guidelines on extended set change policies to support conservation efforts in the event of low inventories or backorder situations for the BD Alaris™ Pump Module administration set.
Q.
Which disinfectants against SARS-CoV-2, the cause of COVID-19, are also approved cleaning products for the Alaris™ System?
A.
The US Environmental Protection Agency (EPA) published a list of products that meet their criteria for use against SARS-CoV-2, the cause of COVID-19. The following products from the EPA list are also approved cleaners listed in the Cleaning Product Guidelines for the Alaris™ System:
- 10% bleach (sodium hypochlorite, one-part bleach to nine parts water)
- Clorox Healthcare® Bleach Germicidal Wipes
- PDI® Super Sani-Cloth® germicidal disposable wipes (purple-top)
- Wexford Labs Wex-Cide 128 concentrate germicidal detergent
For more information on COVID-19 disinfectants, please refer to:
Q.
Can the Alaris™ System be used in improvised emergency response clinical areas such as outdoor tents?
A.
The Alaris™ System can be used with the following environmental specifications as defined in the BD Alaris™ System User Manual. Note: Do not place pumps in direct sunlight.
| Symbol | Meaning | Operating | Storage/Transport |
|---|---|---|---|
| Atmospheric Pressure | 525 - 4560 mmHg (0.7 - 6.08 kPa) | 5 - 85% Noncondensing | |
| Relative Humidity (Avoid prolonged exposure to relative humidity >85%) | 20 - 90% Noncondensing | 5 - 85% Noncondensing | |
| Temperature Range | 41 - 104°F (50 - 40°C) | -4 - 140°F (-20 - 60°C) |
Q.
Can the BD Alaris™ PCA Module be used for continuous infusions outside analgesics?
A.
Due to the COVID-19 crisis, customers are considering all equipment and mode of use to fulfill their infusion needs. If you would like to use the BD Alaris™ PCA Module for continuous infusions, please refer to the following clinical guidelines.